Independent-sample t-tests revealed that TM9SF1 expression levels were also significantly higher among deceased ARDS patients as compared to surviving patients (0.29 ± 0.06 vs. 0.10 ± 0.01, P < 0.001) (Figure 1D). This evidence concerns the gene TM9SF1 and acute respiratory distress syndrome.